Efficacy of Sorafenib for the Treatment of Post-Transplant Hepatocellular Carcinoma Recurrence

BACKGROUND: The role of sorafenib in patients with hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT) has been rarely studied. The aim of this study was to evaluate the efficacy of sorafenib in post-LT era. METHODS: Consecutive patients with post-transplant HCC recurrence not...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Seong Hee, Cho, Hyeki, Cho, Eun Ju, Lee, Jeong-Hoon, Yu, Su Jong, Kim, Yoon Jun, Yi, Nam-Joon, Lee, Kwang-Woong, Suh, Kyung-Suk, Yoon, Jung-Hwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209769/
https://www.ncbi.nlm.nih.gov/pubmed/30402048
http://dx.doi.org/10.3346/jkms.2018.33.e283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209769/
https://www.ncbi.nlm.nih.gov/pubmed/30402048
http://dx.doi.org/10.3346/jkms.2018.33.e283

Ejemplares similares